Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for MediWound (MDWD) over the last 12 years, with Q3 2025 value amounting to $26.3 million.

  • MediWound's Total Current Liabilities rose 264.69% to $26.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.3 million, marking a year-over-year increase of 264.69%. This contributed to the annual value of $26.5 million for FY2024, which is 4643.31% up from last year.
  • Per MediWound's latest filing, its Total Current Liabilities stood at $26.3 million for Q3 2025, which was up 264.69% from $29.1 million recorded in Q2 2025.
  • MediWound's 5-year Total Current Liabilities high stood at $29.1 million for Q2 2025, and its period low was $9.0 million during Q3 2022.
  • For the 5-year period, MediWound's Total Current Liabilities averaged around $17.6 million, with its median value being $18.0 million (2023).
  • In the last 5 years, MediWound's Total Current Liabilities tumbled by 1435.08% in 2021 and then skyrocketed by 11278.22% in 2023.
  • Over the past 5 years, MediWound's Total Current Liabilities (Quarter) stood at $10.7 million in 2021, then increased by 12.46% to $12.1 million in 2022, then skyrocketed by 50.33% to $18.1 million in 2023, then soared by 46.43% to $26.5 million in 2024, then fell by 1.08% to $26.3 million in 2025.
  • Its Total Current Liabilities was $26.3 million in Q3 2025, compared to $29.1 million in Q2 2025 and $21.8 million in Q1 2025.